THE ORIGIN, DIAGNOSIS AND MODERN CLINICAL DIAGNOSTIC METHODS OF MYOCARDIAL INFARCTION
Downloads
Objective: This study aims to explore the origin, diagnosis, and modern clinical diagnostic methods of myocardial infarction, a critical condition caused by the disruption of blood supply to the heart muscle. Method: A comprehensive review of current literature and clinical guidelines was conducted, focusing on the pathophysiological mechanisms, diagnostic criteria, and advancements in diagnostic technologies. The study analyzed data from clinical trials, imaging techniques, and biomarker evaluations to assess the effectiveness of contemporary diagnostic approaches. Results: The findings indicate that myocardial infarction predominantly results from coronary artery occlusion, leading to ischemia and necrosis of the myocardial tissue. Diagnostic advancements include high-sensitivity cardiac troponin assays, electrocardiography (ECG), echocardiography, and coronary angiography, which have significantly improved early detection and risk stratification. Additionally, non-invasive imaging modalities such as cardiac MRI and CT angiography enhance diagnostic accuracy. Novelty: This study highlights the integration of novel biomarkers with advanced imaging techniques as a transformative approach in the early diagnosis and management of myocardial infarction, offering new insights into improving patient outcomes through rapid and precise clinical assessment.
L. Y. L. Chiu, K. Stewart, C. Woo, L. N. Yatham, and R. W. Lam, “The relationship between burnout and depressive symptoms in patients with depressive disorders,” J Affect Disord, vol. 172, pp. 361–366, Feb. 2015, doi: 10.1016/j.jad.2014.10.029.
A. Pitman, “Temporal Risk Factors for Suicide After Suicide Bereavement,” in 2023 Intuition, Imagination and Innovation in Suicidology Conference, Založba Univerze na Primorskem, 2023, p. 15. doi: 10.26493/978-961-293-251-0.6.
A. M. Conjoh, Z. Zhou, and J. Xiong, “Socio-Cultural Factors Affecting the Spread of HIV/AIDS among Adolescents in Sierra Leone,” The Social Sciences, vol. 6, no. 4, pp. 269–276, Apr. 2011, doi: 10.3923/sscience.2011.269.276.
O. Pityk, “Alexithymia and Non-Psychotic Mental Disorders in Patients with Hypothyroidism,” Feb. 2018, doi: 10.26226/morressier.5a6ef3ebd462b80290b57fd0.
J. A. Deisinger, “Diagnosis and assessment of autistic spectrum disorders,” in Autistic Spectrum Disorders: Educational and Clinical Interventions, Emerald (MCB UP ), pp. 181–209. doi: 10.1016/s0270-4013(01)80013-1.
S. M. Labott, “Ethics and professional issues.,” in Psychological treatment of patients with chronic respiratory disease., American Psychological Association, 2020, pp. 139–148. doi: 10.1037/0000189-012.
A. Javaid, “The Sadness of Goats,” in Dwelling Together. Urban Housing, Neighborliness and Multilocal Homemaking, PubPub, 2023. doi: 10.21428/f4c6e600.00fcd79f.
P. Chassagne and S. N’Guyen, “Hydratation et natrémie,” in Gériatrie, Elsevier, 2023, pp. 356–360. doi: 10.1016/b978-2-294-77815-5.00039-1.
C. S. Copeland, “Commentary on Craft et al.: Drug contaminants and substitutions in illicit vapes represent a major health risk,” Addiction, Jan. 2025, doi: 10.1111/add.16777.
S. P S, “Understanding the Complexities of Adolescent Drug Abuse: Causes, Consequences, and Prevention - A Review Article,” International Journal of Science and Research (IJSR), vol. 12, no. 8, pp. 1404–1407, Aug. 2023, doi: 10.21275/sr23814151343.
E. Kraepelin, “Lecture XXIII: Senile dementia.,” in Lectures on clinical psychiatry., William Wood & Co, 1904, pp. 221–230. doi: 10.1037/10789-023.
H. Elkis, D. L. Melzer-Ribeiro, and I. C. Napolitano, “Response to Markota et al. ‘Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia’ SCHRES-D-24-00481,” Schizophr Res, vol. 272, pp. 110–111, Oct. 2024, doi: 10.1016/j.schres.2024.08.003.
J. D. Rawat and S. Singh, “Disorder of Testicular Development,” in Children with Differences in Sex Development, Springer Nature Singapore, 2024, pp. 245–251. doi: 10.1007/978-981-97-1639-5_22.
N. Nacca, D. Vatti, R. Sullivan, P. Sud, M. Su, and J. Marraffa, “The Synthetic Cannabinoid Withdrawal Syndrome,” J Addict Med, vol. 7, no. 4, pp. 296–298, Jul. 2013, doi: 10.1097/adm.0b013e31828e1881.
R. L. Nail and L. M. Dean, “Drug abuse: A manifestation of the cyclic nature of human behavior,” Drug Alcohol Depend, vol. 1, no. 6, pp. 429–434, Oct. 1976, doi: 10.1016/0376-8716(76)90007-7.
V. I. Borodin and I. I. Puchkov, “P.1.023 Clinical and psychological predictorsof pharmacotherapy refusals in patients with non-psychotic depressions,” European Neuropsychopharmacology, vol. 15, pp. S115–S116, Jan. 2005, doi: 10.1016/s0924-977x(05)80251-2.
I. Belokrylov, “The Effectiveness of Psychoanalytic Psychotherapy in the Somatoform Disorders Treatment,” Feb. 2018, doi: 10.26226/morressier.5a7070ded462b80290b56a4a.
A. K. Bachu, “Mal de Débarquement Syndrome Complicated by Psychiatric Comorbidities: Response to Maruta et al,” Prim Care Companion CNS Disord, vol. 25, no. 4, Jul. 2023, doi: 10.4088/pcc.23lr03518a.
B. Barahona-Corrêa, “The High-Functioning Group: High-Functioning Autism and Asperger Syndrome in Adults,” in Autism Spectrum Disorders in Adults, Springer International Publishing, 2017, pp. 129–178. doi: 10.1007/978-3-319-42713-3_5.
A. Zabotina, A. Taraskina, and E. Krupitsky, “Risk for antipsychotic-induced extrapyramidal symptoms: a focus on monoamine receptors on peripheral blood lymphocytes,” Sep. 2018, doi: 10.26226/morressier.5b681761b56e9b005965c39d.
“A Companion to Cognitive Science,” in A Companion to Cognitive Science, Blackwell Publishing Ltd, 1999, pp. 282–288. doi: 10.1111/b.9780631218517.1999.00022.x.
Copyright (c) 2025 Appazova Lenura Madjidovna, Shaymatova Dil'shod Firdavsovna, Uzoqova Oyjamol Narzullayevna
This work is licensed under a Creative Commons Attribution 4.0 International License.
